Topography of Cross-sectional and Longitudinal Glucose Metabolic Deficits in Alzheimer's Disease: Pathophysiologic Implications

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

The cholinergic hypothesis of geriatric memory dysfunction

Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545

The Global Deterioration Scale for assessment of primary degenerative dementia

Reisberg, ‌., Ferris, S. H., de Leon, M. J., & Crook, T. H. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 5,122

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736

Brain energy metabolism

Siesjö, B. K. (1978) · Medical Entomology and Zoology · Cited by 1,426

Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

Hamacher, K., Coenen, H. H., & Stöcklin, G. (1986) · PubMed · Cited by 1,368

Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced

Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 961

Amino acid neurotransmitters and their pathways in the mammalian central nervous system

Fagg, G. E., & Foster, A. C. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90263-4 · Cited by 651

Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites

Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Hänicke, W., & Sauter, R. (1989) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910110105 · Cited by 522

Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E

Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366

Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease

Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977

Positron Emission Tomography in Evaluation of Dementia

Silverman, D. H. S., Small, G. W., Chang, C. Y., Lu, C. S., de Aburto, M. A. K., Chen, W., Czernin, J. G., Rapoport, S. I., Pietrini, P., Alexander, G. E., et al. (2001) · JAMA · doi:10.1001/jama.286.17.2120 · Cited by 960

A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease

Laxton, A. W., Tang‐Wai, D. F., McAndrews, M. P., Zumsteg, D., Wennberg, R. A., Keren, R., Wherrett, J. R., Naglie, G., Hamani, C., Smith, G. S., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22089 · Cited by 827

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons

Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585

Glucose transporters in brain in health and disease

Koepsell, H. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02441-x · Cited by 558

Hippocampal formation glucose metabolism and volume losses in MCI and AD

De Santi, S., de Leon, M. J., Rusinek, H., Convit, A., Tarshish, C. Y., Roche, A., Tsui, W. H., Kandil, E., Boppana, M., Daisley, K., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00230-5 · Cited by 548

Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studies

Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.738 · Cited by 532

Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease

Liu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., Iqbal, K., & Gong, C.-X. (2009) · Brain · doi:10.1093/brain/awp099 · Cited by 439

PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of Dementia

Qin, W., Haroutunian, V. H., Katsel, P., Cardozo, C. P., Ho, L., Buxbaum, J. D., & Pasinetti, G. M. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.588 · Cited by 393

Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.

Kogure, D., Matsuda, H., Ohnishi, T., Asada, T., Uno, M., Kunihiro, T., Nakano, S., & Takasaki, M. (2000) · PubMed · Cited by 365

FDG PET imaging in patients with pathologically verified dementia.

Hoffman, J. M., Welsh-Bohmer, K. A., Hanson, M., Crain, B. J., Hulette, C. M., Earl, N., & Coleman, R. E. (2000) · PubMed · Cited by 350

Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease

Korte, N., Nortley, R., & Attwell, D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02215-w · Cited by 365

A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease

Lozano, A. M., Fosdick, L., Chakravarty, M. M., Leoutsakos, J., Munro, C. A., Oh, E. S., Drake, K. E., Lyman, C. H., Rosenberg, P. B., Anderson, W. S., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160017 · Cited by 342

Patterns of Motor Impairment in Normal Aging, Mild Cognitive Decline, and Early Alzheimer' Disease

Kluger, A., Gianutsos, J. G., Golomb, J. B., Ferris, S. H., GEORGE, A. E., Franssen, E., & Reisberg, ‌. (1997) · The Journals of Gerontology Series B · doi:10.1093/geronb/52b.1.p28 · Cited by 304

The role of glucose transporters in brain disease: Diabetes and Alzheimer’s disease

Shah, K., DeSilva, S., & Abbruscato, T. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012629 · Cited by 288

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Langbaum, J. B. S., Chen, K., Lee, W., Reschke, C., Bandy, D., Fleisher, A. S., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.072 · Cited by 279

Cognitive effects of insulin in the central nervous system

Park, C. R. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00016-1 · Cited by 270

Association of Life Activities With Cerebral Blood Flow in Alzheimer Disease: Implications for the Cognitive Reserve Hypothesis

Scarmeas, N., Zarahn, E., Anderson, K. E., Habeck, C. G., Hilton, J., Flynn, J., Marder, K. S., Bell, K. L., Sackeim, H. A., Van Heertum, R. L., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.359 · Cited by 254

Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease

Matsuda, H. (2001) · Annals of Nuclear Medicine · doi:10.1007/bf02988596 · Cited by 233

Neuroimaging in Alzheimer disease: an evidence-based review

Kantarci, K., & Jack, C. R. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00025-x · Cited by 230

Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease

Moats, R. A., Ernst, T. M., Shonk, T. K., & Ross, B. D. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910320115 · Cited by 216

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

Kantarci, K., Weigand, S. D., Petersen, R. C., Boeve, B. F., Knopman, D. S., Gunter, J. L., Reyes, D. A., Shiung, M. S., O’Brien, P. C., Smith, G. E., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.018 · Cited by 213

Positron emission tomography imaging in dementia

HERHOLZ, K., CARTER, S. F., & JONES, M. (2007) · The British Journal of Radiology · doi:10.1259/bjr/97295129 · Cited by 287

The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease

Sultzer, D. L., Mahler, M. E., Mandelkern, M. A., Cummings, J. L., van Gorp, W. G., Hinkin, C. H., & Berisford, M. A. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.4.476 · Cited by 198

Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline

Chornenkyy, Y., Wang, W., Wei, A. L., & Nelson, P. T. (2018) · Brain Pathology · doi:10.1111/bpa.12655 · Cited by 189

Increased Cerebral Metabolism After 1 Year of Deep Brain Stimulation in Alzheimer Disease

Smith, G. S., Laxton, A. W., Tang‐Wai, D. F., McAndrews, M. P., Diaconescu, A. O., Workman, C. I., & Lozano, A. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.590 · Cited by 180

Cortisol Reduces Hippocampal Glucose Metabolism in Normal Elderly, but Not in Alzheimer's Disease

de Leon, M. J., McRae, T., Rusinek, H., Convit, A. J., Santi, S. D., Tarshish, C. Y., Golomb, J. B., Volkow, N. D., Daisley, K., Orentreich∥, N., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4305 · Cited by 176

Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load.

Bozzao, A., Floris, R., Baviera, M. E., Apruzzese, A., & Simonetti, G. (2001) · PubMed Central · Cited by 164

Cellular Mechanisms of Brain Energy Metabolism. Relevance to Functional Brain Imaging and to Neurodegenerative Disordersa

Magistretti, P. J., & Pellerin, L. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34449.x · Cited by 159

Mitoenergetic failure in Alzheimer disease

Parihar, M. S., & Brewer, G. J. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00232.2006 · Cited by 153

Hypoxia‐inducible factors as neuroprotective agent in Alzheimer's disease

Ashok, B. S., Ajith, T. A., & Sivanesan, S. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12717 · Cited by 150

Reduced functional brain activity response in cognitively intact apolipoprotein E ε4 carriers

Lind, J., Persson, J., Ingvar, M., Larsson, A., Cruts, M., Broeckhoven, C. V., Adolfsson, R., Bäckman, L., Nilsson, L., Petersson, K. M., et al. (2006) · Brain · doi:10.1093/brain/awl054 · Cited by 149

A Meta-Analysis of Structural and Functional Brain Imaging in Dementia of the Alzheimer's Type: A Neuroimaging Profile

Zakzanis, K. K., Graham, S. J., & Campbell, Z. (2003) · Neuropsychology Review · doi:10.1023/a:1022318921994 · Cited by 145

Cortical Abnormalities Associated With Subcortical Lesions in Vascular Dementia

Sultzer, D. L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540320049012 · Cited by 139

Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine.

Harris, G. J., Lewis, R. F., Satlin, A., English, C. D., Scott, T. M., Yurgelun-Todd, D. A., & Renshaw, P. F. (1998) · PubMed Central · Cited by 132

Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice

Chen, Y., Yang, Z., Dai, C., Liang, Z., Run, X., Iqbal, K., Liu, F., & Gong, C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.004 · Cited by 123

Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fasting

Li, X., Fen, L., Wang, J., & Gong, C. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04735.x · Cited by 116

Mitochondrial aging and dysfunction in Alzheimer's disease

Sullivan, P. G., & Brown, M. R. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.12.007 · Cited by 114

Intracerebroventricular Streptozotocin Exacerbates Alzheimer-Like Changes of 3xTg-AD Mice

Chen, Y., Liang, Z., Tian, Z., Blanchard, J., Dai, C., Chalbot, S., Iqbal, K., Liu, F., & Gong, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8539-y · Cited by 117

Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention

Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110

Molecular imaging of serotonin degeneration in mild cognitive impairment

Smith, G. S., Barrett, F. S., Joo, J. H., Nassery, N., Savonenko, A. V., Sodums, D. J., Marano, C. M., Munro, C. A., Brandt, J., Kraut, M. A., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.007 · Cited by 102

Perfusion abnormalities in prodromal AD

Johnson, K. A., & Albert, M. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00137-8 · Cited by 104

Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance

Scarmeas, N., Habeck, C. G., Zarahn, E., Anderson, K. E., Park, A., Hilton, J., Pelton, G. H., Tabert, M. H., Honig, L. S., Moeller, J. R., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.04.032 · Cited by 102

The Neurologic Syndrome of Severe Alzheimer's Disease

Franssen, E. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540100024010 · Cited by 98

PET/CT in diagnosis of dementia

Berti, V., Pupi, A., & Mosconi, L. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06015.x · Cited by 95

Rapid Modulation of Protein Expression in the Rat Hippocampus Following Deep Brain Stimulation of the Fornix

Gondard, E., Chau, H. N., Mann, A., Tierney, T. S., Hamani, C., Kalia, S. K., & Lozano, A. M. (2015) · Brain stimulation · doi:10.1016/j.brs.2015.07.044 · Cited by 94

From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum

Ouellette, J., & Lacoste, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749026 · Cited by 91

In Vivo Structural Studies of the Hippocampus in Normal Aging and in Incipient Alzheimer's Diseasea

de Leon, M. J., Convit, A. J., GEORGE, A. E., Golomb, J. B., Santi, S. D., Tarshish, C. Y., Rusinek, H., Bobinski, M., INCE, C., MILLER, D., et al. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34395.x · Cited by 90

Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance.

Celsis, P., Agniel, A., Cardebat, D., Démonet, J., Ousset, P., & Puel, M. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.6.601 · Cited by 81

Functional O-GlcNAc modifications: Implications in molecular regulation and pathophysiology

Vaidyanathan, K., Durning, S. P., & Wells, L. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.884535 · Cited by 81

Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: A SPECT blood flow study

Brown, D. R., Hunter, R., Wyper, D., Patterson, J. C., Kelly, R. C., Montaldi, D., & McCulloch, J. (1996) · Journal of Psychiatric Research · doi:10.1016/0022-3956(95)00032-1 · Cited by 79

Quantitative EEG and dynamic susceptibility contrast MRI in Alzheimer's disease: a correlative study

Mattia, D., Babiloni, F., Romigi, A., Cincotti, F., Bianchi, L., Sperli, F., Placidi, F., Bozzao, A., Giacomini, P., Floris, R., et al. (2003) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00085-3 · Cited by 80

Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD

Silverman, D. H. S., Geist, C. L., Kenna, H. A., Williams, K. E., Wroolie, T., Powers, B. N., Brooks, J. O., & Rasgon, N. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.002 · Cited by 80

Presenilin-1–associated abnormalities in regional cerebral perfusion

Johnson, K. A., Lopera, F. J., Jones, K., Becker, A., Sperling, R. A., Hilson, J., Londono, J., Siegert, I., Arcos‐Burgos, M., Moreno, S., et al. (2001) · Neurology · doi:10.1212/wnl.56.11.1545 · Cited by 76

Temporal Lobe Perfusion on Single Photon Emission Computed Tomography Predicts the Rate of Cognitive Decline in Alzheimer's Disease

Wolfe, N., Reed, B. R., Eberling, J. L., & Jagust, W. J. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540270049018 · Cited by 74

A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease

Cioffi, F., Adam, R. H. I., Bansal, R., & Broersen, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210497 · Cited by 73

Inactivation and Reactivation of the Mitochondrial α-Ketoglutarate Dehydrogenase Complex

Shi, Q., Xu, H., Yu, H., Zhang, N., Ye, Y., Estévez, Á. G., Deng, H., & Gibson, G. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203018 · Cited by 72

Mild cognitive impairment: historical development and summary of research

Golomb, J. B., Kluger, A., & Ferris, S. H. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.4/jgolomb · Cited by 69

Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease

Harris, G. J., Lewis, R. F., Satlin, A., English, C. D., Scott, T. M., Yurgelun-Todd, D. A., & Renshaw, P. F. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.5.721 · Cited by 67

Clinical studies in Alzheimer patients with positron emission tomography

Nordberg, A. K. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90138-g · Cited by 66

Reassessment of Pioglitazone for Alzheimer’s Disease

Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 71

Mitochondrial Dysfunction in Neurodegeneration

Cooper, J. A. D., & Schapira, A. H. V. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022642114734 · Cited by 64

Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study

Caselli, R. J., Osborne, D., Reiman, E. M., Hentz, J. G., Barbieri, C. J., Saunders, A. M., Hardy, J., Graff‐Radford, N. R., Hall, G. R., & Alexander, G. E. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00577-9 · Cited by 62

The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells

Webster, M.-T., Pearce, B. R., Bowen, D. M., & Francis, P. T. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050098 · Cited by 62

Novel functions of the α-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease

Shi, Q., Xu, H., Kleinman, W. A., & Gibson, G. E. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.12.008 · Cited by 62

The Significance of Glucose Turnover in the Brain in the Pathogenetic Mechanisms of Alzheimer's Disease

Meier‐Ruge, W., & Bertoni–Freddari, C. (1996) · Reviews in the Neurosciences · doi:10.1515/revneuro.1996.7.1.1 · Cited by 60

Rethinking Alzheimer's Disease Therapy: Are Mitochondria the Key?

Ankarcrona, M., Mangialasche, F., & Winblad, B. G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100327 · Cited by 60

Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease

Weidling, I. W., & Swerdlow, R. H. (2019) · Biology · doi:10.3390/biology8020039 · Cited by 59

THE HIPPOCAMPUS IN AGING AND ALZHEIMER'S DISEASE

de Leon, M. J., Convit, A. J., DeSanti, S., Golomb, J. B., Tarshish, C. Y., Rusinek, H., Bobinski, M., Ince, C., Miller, D. C., Wı́sniewski, H. M., et al. (1995) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00272-2 · Cited by 59

Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice

Yu, Y., Li, X., Blanchard, J., Li, Y., Iqbal, K., Liu, F., & Gong, C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1294-z · Cited by 60

Hippocampal changes in STZ-model of Alzheimer’s disease are dependent on sex

Biasibetti, R., dos Santos, J. P. A., Rodrigues, L., Wartchow, K. M., Suardi, L. Z., Nardin, P., Selistre, N. G., Vázquez, D., & Gonçalves, C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.057 · Cited by 64

Mitochondria, Amyloid β, and Alzheimer′s Disease

Readnower, R. D., Sauerbeck, A. D., & Sullivan, P. G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/104545 · Cited by 58

Frontal Lobe Hypometabolism Predicts Cognitive Decline in Patients With Lacunar Infarcts

Reed, B., Eberling, J. L., Mungas, D., Weiner, M. W., & Jagust, W. J. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.493 · Cited by 54

A circuit view of deep brain stimulation in Alzheimer’s disease and the possible mechanisms

Yu, D., Yan, H., Zhou, J., Yang, X., Lu, Y., & Han, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0334-4 · Cited by 52

Patterns of cortical activity and memory performance in Alzheimer’s disease

Schröder, J., Buchsbaum, M. S., Shihabuddin, L., Tang, C. Y., Wei, T.-C., Spiegel-Cohen, J., Hazlett, E. A., ABEL, L., Luu-Hsia, C., Ciaravolo, T. M., et al. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00983-5 · Cited by 50

The development of effective biomarkers for Alzheimer's disease: a review

Henry, M. S., Passmore, A. P., Todd, S., McGuinness, B., Craig, D., & Johnston, J. A. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3829 · Cited by 51

Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease

Tramutola, A., Sharma, N. K., Barone, E., Lanzillotta, C., Castellani, A., Iavarone, F., Vincenzoni, F., Castagnola, M., Butterfield, D. A., Gaetani, S., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.017 · Cited by 44

Perfusion SPECT and FDG-PET

Herholz, K. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000937 · Cited by 46

Application of Positron Emission Tomography for Evaluation of Metabolism and Blood Flow in Human Brain: Normal Development, Aging, Dementia, and Stroke

Silverman, D. H. S., & Phelps, M. E. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3236 · Cited by 41

Regional Cerebral Glucose Metabolism and Gait Speed in Healthy Community-Dwelling Older Women

Sakurai, R., Fujiwara, Y., Yasunaga, M., Takeuchi, R., Murayama, Y., Ohba, H., Sakuma, N., Suzuki, H., Oda, K., Sakata, M., et al. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu093 · Cited by 41

Cerebral glucose metabolism, cerebrospinal fluid-β-amyloid1–42 (CSF-Aβ42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients

Stefanova, E. D., Blennow, K., Almkvist, O., Hellström‐Lindahl, E., & Nordberg, A. K. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01384-8 · Cited by 40

Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease

Smith, G. S., Kramer, E., Ma, Y., Hermann, C. R., DHAWAN, V. M., Chaly, T., & Eidelberg, D. (2009) · Brain · doi:10.1093/brain/awn326 · Cited by 38

Combined Study of Cerebral Glucose Metabolism and [ 11 C]Methionine Accumulation in Probable Alzheimer's Disease Using Positron Emission Tomography

Salmon, É., Grégoire, M., Delfiore, G., Lemaire, C. F., Degueldre, C., Franck, G., & Comar, D. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199605000-00006 · Cited by 38

Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease

Hirao, K., Pontone, G. M., & Smith, G. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.010 · Cited by 38

Molecular Neurobiology of Alzheimer's Disease (Syndrome?)

Zubenko, G. S. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709000303 · Cited by 37

Lectin‐affinity chromatography brain glycoproteomics and Alzheimer disease: Insights into protein alterations consistent with the pathology and progression of this dementing disorder

Butterfield, D. A., & Owen, J. B. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000070 · Cited by 38

The rationale for deep brain stimulation in Alzheimer’s disease

Mirzadeh, Z., Bari, A., & Lozano, A. M. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1462-9 · Cited by 38

Failure to modulate neural response to increased task demand in mild Alzheimer's disease: fMRI study of visuospatial processing

Vannini, P., Lehmann, C. U., Dierks, T., Jann, K., Viitanen, M. H., Wahlund, L., & Almkvist, O. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.013 · Cited by 36

One-Year Change in Cerebral Glucose Metabolism in Patients With Alzheimer's Disease

Hirono, N., Hashimoto, M., Ishii, K., Kazui, H., & Mori, E. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.4.488 · Cited by 34

Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

McDonald, T. S., Lerskiatiphanich, T., Woodruff, T. M., McCombe, P., & Lee, J. D. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221135061 · Cited by 36

Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type

Greene, J. D. W., Miles, K. A., & Hodges, J. R. (1996) · Journal of Neurology · doi:10.1007/bf02444012 · Cited by 32

Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T

Smith, G. S., Oeltzschner, G., Gould, N. F., Leoutsakos, J., Nassery, N., Joo, J. H., Kraut, M. A., Edden, R. A. E., Barker, P. B., Wijtenburg, S. A., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.10.011 · Cited by 36

Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4

Arbonés-Mainar, J. M., Johnson, L. A., Altenburg, M. K., Kim, H., & Maeda, N. (2010) · The FASEB Journal · doi:10.1096/fj.10-159517 · Cited by 29

Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease

Reiman, E. M., Caselli, R. J., Alexander, G. E., & Chen, K. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00006-8 · Cited by 28

Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?

Tarawneh, R. (2023) · Biomolecules · doi:10.3390/biom13050830 · Cited by 29

Fluoro-2-Deoxy-D-Glucose (FDG)-PET in APOEε4 Carriers in the Australian Population

Rimajova, M., Lenzo, N. P., Wu, J.-S., Bates, K. A., Campbell, A. M., Dhaliwal, S. S., McCarthy, M., Rodrigues, M. A., Paton, A., Rowe, C. C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13203 · Cited by 32

Calpain I Activation Causes GLUT3 Proteolysis and Downregulation of O-GlcNAcylation in Alzheimer’s Disease Brain

Gu, J., Jin, N., Ma, D., Chu, D., Iqbal, K., Gong, C., & Liu, F. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171047 · Cited by 27

Parietal cortex activation predicts memory decline in apolipoprotein E-εε4 carriers

Lind, J., Ingvar, M., Persson, J., Sleegers, K., Broeckhoven, C. V., Adolfsson, R., Nilsson, L., & Nyberg, L. H. (2006) · Neuroreport · doi:10.1097/01.wnr.0000239954.60695.c6 · Cited by 29

Accelerated hypometabolism with disease progression associated with faster cognitive decline among amyloid positive patients

Yang, Z., Cummings, J. L., Kinney, J. W., Cordes, D., & Initiative, T. A. D. N. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1151820 · Cited by 14

Abnormal Brain Glucose Metabolism in Alzheimer’s Disease, as Measured by Positron Emission Tomography

Rapoport, S. I., Horwitz, B., Grady, C. L., Haxby, J. V., DeCarli, C. S., & Schapiro, M. B. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5931-9_18 · Cited by 59

Cortical abnormalities in Alzheimer's disease

Foster, N. L., Chase, T. N., Mansi, L., Brooks, R., Fedio, P., Patronas, N. J., & Chiro, G. D. (1984) · Annals of Neurology · doi:10.1002/ana.410160605 · Cited by 378

Regional cerebral glucose metabolism and postmortem pathology in Alzheimer’s disease

Mielke, R., Schröder, R., Fink, G. R., Kessler, J., Herholz, K., & Heiß, W.-D. (1996) · Acta Neuropathologica · doi:10.1007/s004010050410 · Cited by 107

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer’s disease

V, I., Alexander, G., ML, F., D, T., Rajapakse, J. C., Rapoport, S. I., Schapiro, M., Horwitz, B., & Pietrini, P. (1998) · CINECA IRIS Institutial research information system (University of Pisa)